Crocus para Disfunción reproductiva femenina (como el síndrome premenstrual o SOP)
Crocus sativus — 4 estudios científicos revisados
Moderate¿Sirve Crocus para disfunción reproductiva femenina (como el síndrome premenstrual o sop)?
Actúa mediante la regulación de hormonas sexuales, la protección contra el estrés oxidativo en el ovario y el útero, y la modulación de la ovulación (PMID 38558480).
Compuestos activos involucrados: Alcaloides, Crocetina, Crocina, Flavonoides, Picrocrocina, Terpenos, Carotenoides
Evidencia Científica
Los siguientes estudios han investigado la relación entre Crocus y disfunción reproductiva femenina (como el síndrome premenstrual o sop):
Therapeutic effects of saffron (Crocus sativus L) on female reproductive system disorders: A systematic review.
The effect of Crocus sativus on several disorders has been discussed or even confirmed, but the efficacy of this herb on the female reproductive system has not been well presented. In this regard, this systematic review comprehensively discussed the efficacy of C. sativus and its main phytochemical compounds on the female reproductive system and its disorders for the first time. In this systematic review, scientific databases, including PubMed, Web of Sciences, Google Scholar, Scopus, and Scientific Information Database, were explored profoundly. In vivo, in vitro, and human studies published
PubMed: 38558480Effects of Crocus sativus on glycemic control and cardiometabolic parameters among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
Metabolic syndrome (MetS) is a cluster of clinical syndromes that is closely associated with an elevated risk of developing atherosclerotic cardiovascular disease. In a series of animal experiments and clinical trials, crocus sativus and its component crocin have demonstrated promising hypoglycemic effects. However, there is currently insufficient evidence regarding their impact on cardiometabolic parameters. Our study aimed to assess the impact of Crocus sativus and crocin on glycemic control in individuals with metabolic syndrome and associated disorders, as well as their potential effects o
PubMed: 38796446The therapeutic potential of Crocus sativus Linn.: A comprehensive narrative review of clinical trials.
Crocus sativus Linn. (Saffron) is valued worldwide for its potential use in the management of various degenerative disorders, including cardiovascular diseases (CVDs), diabetes, cancer, metabolic syndrome (MetS), neurodegenerative diseases, immune disorders, and sexual dysfunction. Previous reports, based on clinical trials, suggest that crocetin, crocin, picrocrocin, and safranal are the main bioactive components of saffron with antioxidant, anti-inflammatory, and anti-apoptotic effects. In this comprehensive narrative review, we studied the recent clinical trials, investigating the medicinal
PubMed: 34532906Impact of
BACKGROUND: Experimental studies demonstrated a positive effect of administration of PURPOSE: To determine if the use of saffron in humans is beneficial to patients with diabetes mellitus (DM) or metabolic syndrome (MS). METHODS: This systematic review includes 14randomized control trials that investigated the impact of saffron administration and its bioactive ingredient crocin on the metabolic profile of patients with DM, MS, prediabetes, and coronary artery disease. We documented the following clinical outcomes: fasting blood glucose (FBG), glycated haemoglobin (HbA1c), total cholesterol, l
PubMed: 32423173Seguridad y Precauciones
En relación con el embarazo y la lactancia, el uso de Crocus sativus debe ser estrictamente supervisado por un profesional de la salud. Aunque se ha documentado su uso en la regulación de trastornos reproductores femeninos y la modulación de hormonas sexuales (PMID 38558480), no existe evidencia clínica suficiente que garantice la seguridad absoluta en mujeres gestantes. Debido a su potencial capacidad para influir en procesos como la ovulación y la función uterina, el consumo de dosis terapéuticas podría interferir con el desarrollo embrionario o la estabilidad hormonal necesaria durante la gestación. No se recomienda su uso en lactancia debido a la falta de estudios que determinen si los compuestos como la crocina o el safranal se excretan en la leche materna y sus posibles efectos neurobiológicos en el lactante. Para niños menores de 12 años, la seguridad no ha sido establecida. Aunque se ha explorado su uso como coadyuvante en el trastorno por déficit de atención e hiperactividad (TDAH) en poblaciones pediátricas (PMID 37864351), la falta de estudios de seguridad a largo plazo en niños pequeños obliga a la precaución.
Perfil completo: Ver todos los usos y evidencia de Crocus →